ArticleMedical oncology (Northwood, London, England)2012

Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancer.

Yan-Xia Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.